Schedule 13D ownership disclosure

IO BIOTECH INC

Common Stock, par value $0.001 per share · CUSIP: 449778109

Event date: 2025-08-11

Filing-level shares
4,981,588.00
Percent of class
7.3%
  • Novo Holdings A/SReported CIK 0001388325

    Shares: 4,981,588.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022324
Form type
SCHEDULE 13D/A
Filer
IO Biotech, Inc.
CIK
CIK 1865494
Filed
Aug 19, 2025
Reporting period
Aug 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub